3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
7
Recruiting
2
Withdrawn
1
Unknown
1
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Myeloproliferative Disorders
1
Interventions
Cisplatin
122
Carboplatin
120
Drug Therapy
104
Bevacizumab
101
Capecitabine
96
Oxaliplatin
95
Radiotherapy
92
Gemcitabine
88
Paclitaxel
87
tislelizumab
84
Cyclophosphamide
83
Specimen Handling
80
pembrolizumab
76
toripalimab
66
Magnetic Resonance Spectroscopy
63
Fluorouracil
61
sintilimab
58
Injections
57
anlotinib
51
Docetaxel
51
Surgical Procedures, Operative
48
130-nm albumin-bound paclitaxel
48
fludarabine
45
Pemetrexed
43
Standard of Care
42
Biopsy
42
venetoclax
41
Irinotecan
41
lenvatinib
40
Leucovorin
40
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Interventional
×
Phlebotomy
×
Clear all
NCT06290765
2025-07-31
PV
PharmaEssentia
Phase 4
Not yet recruiting
70 enrolled